Hostname: page-component-76fb5796d-zzh7m Total loading time: 0 Render date: 2024-04-26T23:48:12.907Z Has data issue: false hasContentIssue false

Serratia marcescans Contamination of Antiseptic Soap Containing Triclosan: Implications for Nosocomial Infection

Published online by Cambridge University Press:  02 January 2015

M. Anita Barry
Affiliation:
Department of Medicine, Division of Infectious Disease, Boston University School of Medicine, Boston City Hospital, Boston, Massachusetts
Donald E. Craven*
Affiliation:
Department of Medicine, Division of Infectious Disease, Boston University School of Medicine, Boston City Hospital, Boston, Massachusetts
Theresa A. Goularte
Affiliation:
Department of Medicine, Division of Infectious Disease, Boston University School of Medicine, Boston City Hospital, Boston, Massachusetts
Deborah A. Lichtenberg
Affiliation:
Department of Medicine, Division of Infectious Disease, Boston University School of Medicine, Boston City Hospital, Boston, Massachusetts
*
Maxwell Finland Laboratory for Infectious Diseases, Boston City Hospital, Boston, MA 02118

Abstract

During a recent investigation in our surgical intensive care unit, we found that several bottles of the antiseptic handwashing soap, OR Scrub®, were contaminated with Serratia marcescens. OR Scrub® contains 1% triclosan, lanolin, and detergents. The antimicrobial efficacy of OR Scrub® was examined in vitro using serial two-fold dilutions of soap inoculated with various concentrations of different nosocomial pathogens. The minimal bactericidal concentration (MBC) of OR Scrub® against Pseudomonas aeruginosa and several strains of S. marcescens was ≤1:2 By comparison, a non-antiseptic soap from the same manufacturer (Wash®) and 4% chlorhexidine (Hibiclens®) had MBCs for all strains tested of at least 1:64. Time-kill curves confirmed the findings of the initial experiments.

This is the first report of extrinsic contamination of antiseptic soap containing triclosan. No infections could be attributed to the contaminated soap, but sporadic outbreaks of Serratia have occurred in the intensive care unit with no identifiable source. Although there have been few studies on the impact of antiseptic soap in reducing nosocomial infection, we question whether a soap with the limitations of OR Scrub® should be used in intensive care units or operating rooms.

Type
Original Articles
Copyright
Copyright © The Society for Healthcare Epidemiology of America 1984

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1.Yu, VL: Serratia marcescens: Historical perspective and clinical review. N Engl J Med 1979;300:887893.CrossRefGoogle ScholarPubMed
2.Sanders, CV, Luby, JP, Johanson, WG, et al: Serratia marcescens infections from inhalation therapy medications: Nosocomial outbreak. Ann Intern Med 1970;73:1521.CrossRefGoogle ScholarPubMed
3.Ringrose, RE, McKown, B, Felton, FG, et al: A hospital outbreak of Serratia marcescens associated with ultrasonic nebulizers. Ann Intern Med 1968;69:719729.CrossRefGoogle ScholarPubMed
4.Rutala, WA, Kennedy, VA, Loflin, HB, et al: Serratia marcescens nosocomial infections of the urinary tract associated with urine measuring containers and urinometers. Am J Med 1981;70:659663.CrossRefGoogle ScholarPubMed
5.Webb, SF, Vall-Spinosa, A: Outbreak of Serratia marcescens associated with the flexible fiberbronchoscope. Chest 1975;68:703708.CrossRefGoogle Scholar
6.Meers, PD, Foster, CS, Churcher, GM: Cross infections with Serratia marcescens. Br Med J 1978;1:238239.CrossRefGoogle ScholarPubMed
7.Maki, DG, Hennekens, CG, Phillips, CW, et al: Nosocomial urinary tract infection with Serratia marcescens: An epidemiologic study. J Infect Dis 1973;128:579587.CrossRefGoogle ScholarPubMed
8.Albert, RK, Condie, F: Handwashing patterns in medical intensive care units. N Engl J Med 1981;304:14651466.CrossRefGoogle ScholarPubMed
9.Burdon, DW, Whitley, JL: Contamination of hospital disinfectants with Pseudomonas species. Br Med J 1967;2:153155.CrossRefGoogle ScholarPubMed
10.Bassett, DCJ, Stokes, KJ, Thomas, WRG: Wound infection with Pseudomonas multivorans. Lancet 1970;1:11881191.CrossRefGoogle ScholarPubMed
11.Sobel, JD, Hashman, N, Reinherz, G, et al: Nosocomial Pseudomonas infection associated with Chlorhexidine contamination. Am J Med 1982;73:183186.CrossRefGoogle ScholarPubMed
12.Marrie, TJ, Costerton, JW: Prolonged survival of Serratia marcescens in Chlorhexidine. Appl Environ Microbiol 1981;42:10931102.CrossRefGoogle ScholarPubMed
13.Sanford, JP: Disinfectants that don't. Ann Intern Med 1970;72:282283.CrossRefGoogle ScholarPubMed
14.Craven, DE, Moody, B, Connolly, MG, et al: Pseudobacteremia caused by povidone-iodine solution contaminated with Pseudomonas cepacia. N Engl J Med 1981;305:621623.CrossRefGoogle ScholarPubMed
15.Sheikh, W: Development and validation of a neutralizer system for in vitro evaluation of some antiseptics. Antimicrob Agents Chemoth 1981;19:429434.CrossRefGoogle ScholarPubMed
16.Bennett, JV: Incidence and nature of endemic and epidemic nosocomial infections, in Bennett, JV, Brachman, PS (eds): Hospital Infections. Boston, Little Brown & Co, 1979.Google Scholar
17.Regos, J, Zak, O, Solf, R, et al: Antimicrobial spectrum of triclosan, a broad spectrum antimicrobial agent for topical application. Dermatatogica 1979;158:7279.CrossRefGoogle ScholarPubMed
18.Over the counter drugs generally recognized as safe effective and not misbranded. Federal Register 1978; 43(Jan 6):12101233.Google Scholar
19.Forfar, JO, Gould, JC, Maccabe, AF: Effect of hexachlorophene on incidence of staphylococcal and gram-negative infection in the newborn. Lancet 1968;2:177180.CrossRefGoogle ScholarPubMed
20.Light, IJ, Sutherland, JM, Cochran, L, et al: Ecologic relation between Staphylococcus aureus and Pseudomonas in a nursery population. N Engl J Med 1968;278:12431247.CrossRefGoogle Scholar
21.Maki, D, Hecht, J: Antiseptic containing handwashing agents reduce nosocomial infection—A prospective study. Read before the Interscience Conference on Antimicrobial Agents and Chemotherapy, Miami Beach, FL, October 4-6, 1982, abstract #699.Google Scholar